Arrieta F, Iglesias P, Aguilar M, Mata P, Pedro-Botet J. Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. ccm [Internet]. 2020 Dec. 3 [cited 2026 Jun. 21];4(6):736-42. Available from: http://www.fortunejournals.org/ojs/index.php/ccm/article/view/15983